Doceree

Overview

Doceree is an AI-powered HCP marketing operating system that delivers contextual, programmatic engagement across point-of-care platforms, medical publishers, and clinical workflows. Its patented Triggers technology enables real-time, HIPAA-compliant messaging within EHRs, eRx, and telehealth systems, on top of HIPAA-certified cookie-free deterministic targeting of 6M+ verified HCPs. The platform integrates DSP, SSP, DMP, and identity resolution under one stack, with a publisher network of 2,000+ specialist medical publishers and 150+ POC platforms.

Doceree is not a full-service healthcare agency, a brand-strategy consultancy, or a patient-marketing platform. It is best evaluated as an HCP marketing technology and media layer; pair with a strategic agency, MLR partner, and creative shop for the rest of the launch communications stack.

Healthcare Marketing Comms Capability Model

The framework below standardizes how Rx Almanac evaluates healthcare-marketing-comms capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Doceree is evaluated as an HCP marketing technology and media layer; pair with a strategic agency, MLR partner, and creative shop for the rest of the launch communications stack.

Capability	Buyer should compare	Doceree readout
Brand strategy and launch planning	Positioning, segmentation, message architecture, launch sequencing, campaign platform, and brand planning.	Not the use case. Doceree is an HCP media and targeting platform, not a strategic agency; pair with a brand-strategy partner for positioning and message architecture work.
HCP media and omnichannel activation	HCP targeting, media, point-of-care, digital, social, congress, rep-triggered, and CRM-connected activation.	Core engagement model. Triggers EHR/eRx workflow integration, 2,000+ medical publishers, 150+ POC platforms, and RepTwin AI virtual rep cover the activation lane end-to-end.
Payer, access, and market access communications	Payer tools, value messages, reimbursement content, access pull-through, and patient-services communications.	Adjacent. The co-pay.com integration adds patient-affordability messaging context; payer-strategy communications are not the headline use case.
Medical/clinical content and MLR operations	Clinical story, claims support, MLR workflows, medical education, scientific accuracy, and compliant content operations.	Confirm medical clinical content in the RFP. Doceree’s strength is media and targeting infrastructure; ask which MLR workflow tools are integrated and which require a separate MLR vendor.
Measurement, targeting, and optimization	Audience data, campaign analytics, attribution, test-and-learn loops, and performance optimization.	Core analytics use case. HIPAA-certified cookie-free deterministic targeting of 6M+ verified HCPs; DataIQ HCP intelligence layer; physician-level outcome measurement.
Agency integration and execution capacity	Creative, media, PR, medical, access, production, localization, and account-service capacity.	Documented as platform layer. Doceree is best deployed alongside a creative agency, MLR partner, and brand-strategy team; ask how the platform integrates with the manufacturer’s existing agency stack.

Buyer Fit

• Buyer trigger: Pharma manufacturers wanting an HCP marketing technology and media layer with patented EHR/eRx integration, deterministic HCP identity, and point-of-care reach.
• Best-fit buyers: Small molecule, biologics, and specialty brands where HCP-level targeting, contextual messaging in clinical workflows, and physician-level measurement materially shape launch reach.
• Less ideal fit: Manufacturers looking for a strategic creative agency, full-service brand consultancy, or end-to-end MLR operations partner; Doceree complements those, it does not replace them.
• Commercial fit: Subscription-based pricing; confirm media transparency, identity-graph access, performance reporting cadence, and how subscription levels gate POC and EHR inventory.
• Integration diligence: Therapy expertise, MLR workflow integration, data and identity assets, media transparency, measurement methodology, opt-in basis for HCP identity, and how the platform integrates with the manufacturer’s existing agency and CRM stack.

Differentiators

• Patented Triggers technology: Real-time HIPAA-compliant messaging delivered inside EHR, eRx, and telehealth workflows at the point of care; distinct from generic display or programmatic HCP media.
• Network scale: 2,000+ specialist medical publishers plus 150+ point-of-care platforms, giving Doceree contextual reach beyond a single endemic publisher.
• Deterministic HCP identity: HIPAA-certified cookie-free deterministic targeting of 6M+ verified HCPs; supports specialty and behavior-driven segmentation for omnichannel campaigns.
• RepTwin AI virtual rep: AI virtual rep layer for scalable HCP engagement; PM360 2025 AI Innovator award.
• co-pay.com affordability integration: Patient-affordability database integrated into the marketing platform, with March 2026 leadership hires (ex-GoodRx) signaling continued investment in the affordability lane.

RFP Questions

• Which EHR, eRx, and telehealth platforms does the Triggers technology integrate with for the manufacturer’s target HCP segment?
• What portion of the plan is owned Doceree inventory versus partner media, programmatic, or POC platforms?
• How will Doceree verify HCP identity, specialty, engagement quality, and campaign attribution?
• What MLR workflow tools are integrated, and where will the manufacturer need a separate MLR vendor or agency?
• How does Doceree coordinate with the manufacturer’s existing creative agency, brand-strategy partner, and CRM systems?
• Which targeting, identity, media, and measurement assets are proprietary versus partner-sourced, and what permissions govern their use?
• What patient-affordability and access messaging is enabled through the co-pay.com integration, and how is it MLR-reviewed?

Recent Activity

• 2026-05 - Current Doceree materials position the company as an HCP marketing platform with Daily Command, Spark, co-pay.com, Kythera RWD integration, and RepTwin roadmap language to diligence carefully.

• 2026-03: Strategic Growth Team formalized; Paresh Rajpurohit (VP Corporate Development) and Andreas Tsitsos hired to lead a disciplined M&A agenda targeting data, AI, and patient affordability acquisitions.

• 2026-03: Andrew Matthews appointed SVP Patient Affordability (ex-GoodRx) to scale the co-pay.com affordability intelligence platform.

• 2026-03: Partnered with Kythera Labs for RWD insights integration into the engagement platform.

• 2026-01: CES presence reinforcing HCP marketing leadership positioning.

• 2025: RepTwin AI virtual brand representative launched at Fierce Pharma Week; won PM360 2025 AI Innovator award.